Concepedia

Csaba Szántai-Kis

CS

Statistics

Publications

20

Citations

667

H-Index

14

Active since

2003

Affiliations

Vichem Chemie (Hungary)(Current)

Semmelweis University

Max Planck Institute of Biochemistry

Max Planck Society

Hungarian Academy of Sciences

Csaba Szántai-Kis is an author at Vichem Chemie (Hungary) specializing in drug discovery, pharmacology, and drug design.

ORCID

Publications per year

2003–2019

20

Publications

20

NADPH Oxidase 4 Is Expressed in Pulmonary Artery Adventitia and Contributes to Hypertensive Vascular Remodeling

Scott A. Barman, Feng Chen, Yunchao Su et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2014 · 119 citations · Full text

, , +17

Leads for antitubercular compounds from kinase inhibitor library screens

Sophie Magnet, Ruben C. Hartkoorn, Rita Székely et al. · Tuberculosis · 2010 · 104 citations · Full text

, , +14

Signal Transduction Therapy with Rationally Designed Kinase Inhibitors

Gÿorgý Kéri, László Őrfi, Dániel Erös et al. · Current Signal Transduction Therapy · 2006 · 48 citations

, , +17

Comparison of Predictive Ability of Water Solubility QSPR Models Generated by MLR, PLS and ANN Methods

Dániel Erös, Gÿorgý Kéri, István Kövesdi et al. · Mini-Reviews in Medicinal Chemistry · 2004 · 41 citations

, , +17

Design and synthesis of new imidazo[1,2- a ]pyridine and imidazo[1,2- a ]pyrazine derivatives with antiproliferative activity against melanoma cells

Rita Garamvölgyi, Judit Dobos, Anna Sipos et al. · European Journal of Medicinal Chemistry · 2015 · 38 citations · Full text

, , +10

1–5 of 20